Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 363

    1.

    Patient, Physician, and Payment Predictors of Statin Adherence.

    Chan DC, Shrank WH, Cutler D, Jan S, Fischer MA, Liu J, Avorn J, Solomon D, Brookhart MA, Choudhry NK.

    Med Care. 2009 Nov 18. [Epub ahead of print]PMID: 19890219 [PubMed - as supplied by publisher]Related articles

    2.

    NSAID switching and short-term gastrointestinal outcome rates after the withdrawal of rofecoxib.

    Schneeweiss S, Glynn RJ, Avorn J, Mamdani M, Mogun H, Solomon DH.

    Pharmacoepidemiol Drug Saf. 2009 Oct 20. [Epub ahead of print]PMID: 19844943 [PubMed - as supplied by publisher]Related articles

    3.

    Balancing innovation, access, and profits--market exclusivity for biologics.

    Engelberg AB, Kesselheim AS, Avorn J.

    N Engl J Med. 2009 Nov 12;361(20):1917-9. Epub 2009 Oct 14. No abstract available. PMID: 19828525 [PubMed - in process]Related articles

    4.

    Differences in adverse effect reporting in placebo groups in SSRI and tricyclic antidepressant trials: a systematic review and meta-analysis.

    Rief W, Nestoriuc Y, von Lilienfeld-Toal A, Dogan I, Schreiber F, Hofmann SG, Barsky AJ, Avorn J.

    Drug Saf. 2009;32(11):1041-56. doi: 10.2165/11316580-000000000-00000.PMID: 19810776 [PubMed - in process]Related articles

    5.

    An evaluation of the relationship between the implementation of a newly designed prescription drug label at Target pharmacies and health outcomes.

    Shrank WH, Patrick A, Gleason PP, Canning C, Walters C, Heaton AH, Jan S, Brookhart MA, Schneeweiss S, Solomon DH, Wolf MS, Avorn J, Choudhry NK.

    Med Care. 2009 Sep;47(9):1031-5.PMID: 19648829 [PubMed - indexed for MEDLINE]Related articles

    6.

    Managing drug-risk information--what to do with all those new numbers.

    Avorn J, Schneeweiss S.

    N Engl J Med. 2009 Aug 13;361(7):647-9. Epub 2009 Jul 27. No abstract available. PMID: 19635948 [PubMed - indexed for MEDLINE]Related articles

    7.

    Imuunosuppressants, mortality, and risk of cancer.

    Avorn J, Schneeweiss S.

    BMJ. 2009 Jul 3;339:b1645. doi: 10.1136/bmj.b1645. No abstract available. PMID: 19578084 [PubMed - indexed for MEDLINE]Related articles

    8.

    Interventions to improve adherence and persistence with osteoporosis medications: a systematic literature review.

    Gleeson T, Iversen MD, Avorn J, Brookhart AM, Katz JN, Losina E, May F, Patrick AR, Shrank WH, Solomon DH.

    Osteoporos Int. 2009 Jun 5. [Epub ahead of print]PMID: 19499273 [PubMed - as supplied by publisher]Related articles

    9.

    Using patent data to assess the value of pharmaceutical innovation.

    Kesselheim AS, Avorn J.

    J Law Med Ethics. 2009 Summer;37(2):176-83.PMID: 19493065 [PubMed - in process]Related articles

    10.

    High-dimensional propensity score adjustment in studies of treatment effects using health care claims data.

    Schneeweiss S, Rassen JA, Glynn RJ, Avorn J, Mogun H, Brookhart MA.

    Epidemiology. 2009 Jul;20(4):512-22.PMID: 19487948 [PubMed - indexed for MEDLINE]Related articles

    11.

    A blinded randomized controlled trial of motivational interviewing to improve adherence with osteoporosis medications: design of the OPTIMA trial.

    Solomon DH, Gleeson T, Iversen M, Avorn J, Brookhart MA, Lii J, Losina E, May F, Patrick A, Shrank WH, Katz JN.

    Osteoporos Int. 2009 May 13. [Epub ahead of print]PMID: 19436935 [PubMed - as supplied by publisher]Related articles

    12.

    Debate about funding comparative-effectiveness research.

    Avorn J.

    N Engl J Med. 2009 May 7;360(19):1927-9. No abstract available. PMID: 19420361 [PubMed - indexed for MEDLINE]Related articles

    13.

    Rationale and design of the Study Assessing the Effect of Cardiovascular Medications Provided as Low-cost, Evidence-based Generic Samples (SAMPLES) trial.

    Shrank WH, Choudhry NK, Solomon DH, Snedden TM, Lee TH, Glynn RJ, Brown TV, Jolda C, Spetman M, Brookhart MA, Schneeweiss S, Avorn J.

    Am Heart J. 2009 Apr;157(4):613-9. Epub 2009 Feb 11.PMID: 19332186 [PubMed - indexed for MEDLINE]Related articles

    14.

    Can improved prescription medication labeling influence adherence to chronic medications? An evaluation of the target pharmacy label.

    Shrank WH, Gleason PP, Canning C, Walters C, Heaton AH, Jan S, Patrick A, Brookhart MA, Schneeweiss S, Solomon DH, Avorn J, Choudhry NK.

    J Gen Intern Med. 2009 May;24(5):570-8. Epub 2009 Feb 27.PMID: 19247719 [PubMed - in process]Related articles

    15.

    Communicating drug benefits and risks effectively: there must be a better way.

    Avorn J, Shrank WH.

    Ann Intern Med. 2009 Apr 21;150(8):563-4. Epub 2009 Feb 24. No abstract available. PMID: 19240226 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Pharmacological management of osteoporosis in nursing home populations: a systematic review.

    Parikh S, Avorn J, Solomon DH.

    J Am Geriatr Soc. 2009 Feb;57(2):327-34. Review.PMID: 19207148 [PubMed - indexed for MEDLINE]Related articles

    17.

    Is there a relationship between patient beliefs or communication about generic drugs and medication utilization?

    Shrank WH, Cadarette SM, Cox E, Fischer MA, Mehta J, Brookhart AM, Avorn J, Choudhry NK.

    Med Care. 2009 Mar;47(3):319-25.PMID: 19194329 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Antipsychotic agents and sudden cardiac death--how should we manage the risk?

    Schneeweiss S, Avorn J.

    N Engl J Med. 2009 Jan 15;360(3):294-6. No abstract available. PMID: 19144946 [PubMed - indexed for MEDLINE]Related articles

    19.

    Comparison of the impact of the Atrial Fibrillation Follow-Up Investigation of Rhythm Management trial on prescribing patterns: a time-series analysis.

    Choudhry NK, Zagorski B, Avorn J, Levin R, Sykora K, Laupacis A, Mamdani M.

    Ann Pharmacother. 2008 Nov;42(11):1563-72. Epub 2008 Sep 30.PMID: 18827174 [PubMed - indexed for MEDLINE]Related articles

    20.

    Drug warnings that can cause fits--communicating risks in a data-poor environment.

    Avorn J.

    N Engl J Med. 2008 Sep 4;359(10):991-4. No abstract available. PMID: 18768941 [PubMed - indexed for MEDLINE]Related articles

    21.

    Development of a health care utilisation data-based index for rheumatoid arthritis severity: a preliminary study.

    Ting G, Schneeweiss S, Scranton R, Katz JN, Weinblatt ME, Young M, Avorn J, Solomon DH.

    Arthritis Res Ther. 2008;10(4):R95. Epub 2008 Aug 21.PMID: 18717997 [PubMed - indexed for MEDLINE]Related articlesFree article

    22.

    Subgroup analyses to determine cardiovascular risk associated with nonsteroidal antiinflammatory drugs and coxibs in specific patient groups.

    Solomon DH, Glynn RJ, Rothman KJ, Schneeweiss S, Setoguchi S, Mogun H, Avorn J, Stürmer T.

    Arthritis Rheum. 2008 Aug 15;59(8):1097-104.PMID: 18668605 [PubMed - indexed for MEDLINE]Related articlesFree article

    23.

    Tumor necrosis factor-alpha antagonist use and heart failure in elderly patients with rheumatoid arthritis.

    Setoguchi S, Schneeweiss S, Avorn J, Katz JN, Weinblatt ME, Levin R, Solomon DH.

    Am Heart J. 2008 Aug;156(2):336-41. Epub 2008 Jun 17.PMID: 18657665 [PubMed - indexed for MEDLINE]Related articles

    24.

    Rationale and design of the Post-MI FREEE trial: a randomized evaluation of first-dollar drug coverage for post-myocardial infarction secondary preventive therapies.

    Choudhry NK, Brennan T, Toscano M, Spettell C, Glynn RJ, Rubino M, Schneeweiss S, Brookhart AM, Fernandes J, Mathew S, Christiansen B, Antman EM, Avorn J, Shrank WH.

    Am Heart J. 2008 Jul;156(1):31-6. Epub 2008 Jun 6.PMID: 18585494 [PubMed - indexed for MEDLINE]Related articlesFree article

    25.

    Propensity Score Calibration and its Alternatives.

    Stürmer T, Schneeweiss S, Rothman KJ, Avorn J, Glynn RJ.

    Am J Epidemiol. 2007;165(10):1122-1123. No abstract available. PMID: 18584066 [PubMed]Related articlesFree article

    26.

    Coagulation and adulteration--building on science and policy lessons from 1905.

    Avorn J.

    N Engl J Med. 2008 Jun 5;358(23):2429-31. No abstract available. PMID: 18525040 [PubMed - indexed for MEDLINE]Related articles

    27.

    Osteoporosis medication use in nursing home patients with fractures in 1 US state.

    Parikh S, Mogun H, Avorn J, Solomon DH.

    Arch Intern Med. 2008 May 26;168(10):1111-5.PMID: 18504340 [PubMed - indexed for MEDLINE]Related articlesFree article

    28.

    The economic consequences of non-evidence-based clopidogrel use.

    Choudhry NK, Levin R, Avorn J.

    Am Heart J. 2008 May;155(5):904-9. Epub 2008 Feb 21.PMID: 18440340 [PubMed - indexed for MEDLINE]Related articles

    29.

    Pharmaceutical promotion to physicians and First Amendment rights.

    Kesselheim AS, Avorn J.

    N Engl J Med. 2008 Apr 17;358(16):1727-32. No abstract available. PMID: 18420505 [PubMed - indexed for MEDLINE]Related articles

    30.

    Adverse Drug Reactions in Elderly People: A substantial cause of preventable illness.

    Avorn J, Shrank WH.

    BMJ. 2008 Apr 26;336(7650):956-7. Epub 2008 Apr 8. No abstract available. PMID: 18397948 [PubMed - indexed for MEDLINE]Related articles

    31.

    The effect of altitude on dosing and response to erythropoietin in ESRD.

    Brookhart MA, Schneeweiss S, Avorn J, Bradbury BD, Rothman KJ, Fischer M, Mehta J, Winkelmayer WC.

    J Am Soc Nephrol. 2008 Jul;19(7):1389-95. Epub 2008 Apr 2.PMID: 18385423 [PubMed - indexed for MEDLINE]Related articlesFree article

    32.

    The impact of cost sharing on antidepressant use among older adults in British Columbia.

    Wang PS, Patrick AR, Dormuth CR, Avorn J, Maclure M, Canning CF, Schneeweiss S.

    Psychiatr Serv. 2008 Apr;59(4):377-83.PMID: 18378836 [PubMed - indexed for MEDLINE]Related articlesFree article

    33.

    Improvements in long-term mortality after myocardial infarction and increased use of cardiovascular drugs after discharge: a 10-year trend analysis.

    Setoguchi S, Glynn RJ, Avorn J, Mittleman MA, Levin R, Winkelmayer WC.

    J Am Coll Cardiol. 2008 Apr 1;51(13):1247-54.PMID: 18371553 [PubMed - indexed for MEDLINE]Related articles

    34.

    Drug-review deadlines and safety problems.

    Carpenter D, Zucker EJ, Avorn J.

    N Engl J Med. 2008 Mar 27;358(13):1354-61.PMID: 18367738 [PubMed - indexed for MEDLINE]Related articlesFree article

    35.

    Cost-effectiveness of providing full drug coverage to increase medication adherence in post-myocardial infarction Medicare beneficiaries.

    Choudhry NK, Patrick AR, Antman EM, Avorn J, Shrank WH.

    Circulation. 2008 Mar 11;117(10):1261-8. Epub 2008 Feb 19.PMID: 18285564 [PubMed - indexed for MEDLINE]Related articlesFree article

    36.

    Pharmacoepidemiology and "in silico" drug evaluation: is there common ground?

    Stürmer T, Rothman KJ, Avorn J.

    J Clin Epidemiol. 2008 Mar;61(3):205-6. No abstract available. PMID: 18226742 [PubMed - indexed for MEDLINE]Related articlesFree article

    37.

    Using computer-based decision support to close the "know do" gap in lipid-lowering therapy.

    Avorn J, Choudhry NK.

    Circulation. 2008 Jan 22;117(3):336-7. Review. No abstract available. PMID: 18212297 [PubMed - indexed for MEDLINE]Related articlesFree article

    38.

    High-risk patients' readiness to undergo BMD testing for osteoporosis diagnosis in Pennsylvania.

    Polinski JM, Cadarette SM, Arnold M, Katz JN, Finkelstein JS, Brookhart MA, Canning C, Avorn J, Solomon DH.

    Int Q Community Health Educ. 2008-2009;29(3):223-40.PMID: 19720587 [PubMed - indexed for MEDLINE]Related articles

    39.

    A cross-national study of the persistence of antihypertensive medication use in the elderly.

    van Wijk BL, Shrank WH, Klungel OH, Schneeweiss S, Brookhart MA, Avorn J.

    J Hypertens. 2008 Jan;26(1):145-53.PMID: 18090552 [PubMed - indexed for MEDLINE]Related articlesFree article

    40.

    In defense of pharmacoepidemiology--embracing the yin and yang of drug research.

    Avorn J.

    N Engl J Med. 2007 Nov 29;357(22):2219-21. No abstract available. PMID: 18046025 [PubMed - indexed for MEDLINE]Related articles

    41.

    Ventricular arrhythmias and cerebrovascular events in the elderly using conventional and atypical antipsychotic medications.

    Wang PS, Schneeweiss S, Setoguchi S, Patrick A, Avorn J, Mogun H, Choudhry NK, Brookhart MA.

    J Clin Psychopharmacol. 2007 Dec;27(6):707-10. No abstract available. PMID: 18004143 [PubMed - indexed for MEDLINE]Related articles

    42.

    Strategies for the management of suspected heparin-induced thrombocytopenia: a cost-effectiveness analysis.

    Patrick AR, Winkelmayer WC, Avorn J, Fischer MA.

    Pharmacoeconomics. 2007;25(11):949-61.PMID: 17960953 [PubMed - indexed for MEDLINE]Related articles

    43.

    Design of cluster-randomized trials of quality improvement interventions aimed at medical care providers.

    Glynn RJ, Brookhart MA, Stedman M, Avorn J, Solomon DH.

    Med Care. 2007 Oct;45(10 Supl 2):S38-43.PMID: 17909381 [PubMed - indexed for MEDLINE]Related articles

    44.

    Adjustments for unmeasured confounders in pharmacoepidemiologic database studies using external information.

    Stürmer T, Glynn RJ, Rothman KJ, Avorn J, Schneeweiss S.

    Med Care. 2007 Oct;45(10 Supl 2):S158-65. Review.PMID: 17909375 [PubMed - indexed for MEDLINE]Related articlesFree article

    45.

    Increasing levels of restriction in pharmacoepidemiologic database studies of elderly and comparison with randomized trial results.

    Schneeweiss S, Patrick AR, Stürmer T, Brookhart MA, Avorn J, Maclure M, Rothman KJ, Glynn RJ.

    Med Care. 2007 Oct;45(10 Supl 2):S131-42.PMID: 17909372 [PubMed - indexed for MEDLINE]Related articles

    46.

    Quality indicators for medication use in vulnerable elders.

    Shrank WH, Polinski JM, Avorn J.

    J Am Geriatr Soc. 2007 Oct;55 Suppl 2:S373-82. Review. No abstract available. PMID: 17910560 [PubMed - indexed for MEDLINE]Related articles

    47.

    Telephone screening, outreach, and care management for depressed workers and impact on clinical and work productivity outcomes: a randomized controlled trial.

    Wang PS, Simon GE, Avorn J, Azocar F, Ludman EJ, McCulloch J, Petukhova MZ, Kessler RC.

    JAMA. 2007 Sep 26;298(12):1401-11.PMID: 17895456 [PubMed - indexed for MEDLINE]Related articlesFree article

    48.

    Ten-year trends of cardiovascular drug use after myocardial infarction among community-dwelling persons > or =65 years of age.

    Setoguchi S, Glynn RJ, Avorn J, Levin R, Winkelmayer WC.

    Am J Cardiol. 2007 Oct 1;100(7):1061-7. Epub 2007 Jul 30.PMID: 17884362 [PubMed - indexed for MEDLINE]Related articles

    49.

    The variability and quality of medication container labels.

    Shrank WH, Agnew-Blais J, Choudhry NK, Wolf MS, Kesselheim AS, Avorn J, Shekelle P.

    Arch Intern Med. 2007 Sep 10;167(16):1760-5.PMID: 17846395 [PubMed - indexed for MEDLINE]Related articlesFree article

    50.

    Uric acid lowering therapy: prescribing patterns in a large cohort of older adults.

    Solomon DH, Avorn J, Levin R, Brookhart MA.

    Ann Rheum Dis. 2008 May;67(5):609-13. Epub 2007 Aug 29.PMID: 17728328 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...